These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Emerging senolytic agents derived from natural products. Li W; Qin L; Feng R; Hu G; Sun H; He Y; Zhang R Mech Ageing Dev; 2019 Jul; 181():1-6. PubMed ID: 31077707 [TBL] [Abstract][Full Text] [Related]
5. Senolytic drugs in respiratory medicine: is it an appropriate therapeutic approach? Cazzola M; Matera MG; Rogliani P; Calzetta L Expert Opin Investig Drugs; 2018 Jul; 27(7):573-581. PubMed ID: 29972333 [TBL] [Abstract][Full Text] [Related]
6. National Institute on Aging Workshop: Repurposing Drugs or Dietary Supplements for Their Senolytic or Senomorphic Effects: Considerations for Clinical Trials. Romashkan S; Chang H; Hadley EC J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1144-1152. PubMed ID: 33528569 [TBL] [Abstract][Full Text] [Related]
7. Discovery of piperlongumine as a potential novel lead for the development of senolytic agents. Wang Y; Chang J; Liu X; Zhang X; Zhang S; Zhang X; Zhou D; Zheng G Aging (Albany NY); 2016 Nov; 8(11):2915-2926. PubMed ID: 27913811 [TBL] [Abstract][Full Text] [Related]
9. Effects of senolytic drugs on human mesenchymal stromal cells. Grezella C; Fernandez-Rebollo E; Franzen J; Ventura Ferreira MS; Beier F; Wagner W Stem Cell Res Ther; 2018 Apr; 9(1):108. PubMed ID: 29669575 [TBL] [Abstract][Full Text] [Related]
10. Pleiotropic Effects of Tocotrienols and Quercetin on Cellular Senescence: Introducing the Perspective of Senolytic Effects of Phytochemicals. Malavolta M; Pierpaoli E; Giacconi R; Costarelli L; Piacenza F; Basso A; Cardelli M; Provinciali M Curr Drug Targets; 2016; 17(4):447-59. PubMed ID: 26343116 [TBL] [Abstract][Full Text] [Related]
11. Identification of gingerenone A as a novel senolytic compound. Moaddel R; Rossi M; Rodriguez S; Munk R; Khadeer M; Abdelmohsen K; Gorospe M; Ferrucci L PLoS One; 2022; 17(3):e0266135. PubMed ID: 35349590 [TBL] [Abstract][Full Text] [Related]
13. Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools. Knoppert SN; Valentijn FA; Nguyen TQ; Goldschmeding R; Falke LL Front Pharmacol; 2019; 10():770. PubMed ID: 31354486 [TBL] [Abstract][Full Text] [Related]
14. Is exercise a senolytic medicine? A systematic review. Chen XK; Yi ZN; Wong GT; Hasan KMM; Kwan JS; Ma AC; Chang RC Aging Cell; 2021 Jan; 20(1):e13294. PubMed ID: 33378138 [TBL] [Abstract][Full Text] [Related]
15. Cellular senescence in the aging and diseased kidney. Valentijn FA; Falke LL; Nguyen TQ; Goldschmeding R J Cell Commun Signal; 2018 Mar; 12(1):69-82. PubMed ID: 29260442 [TBL] [Abstract][Full Text] [Related]
16. Targeting normal and cancer senescent cells as a strategy of senotherapy. Sikora E; Bielak-Zmijewska A; Mosieniak G Ageing Res Rev; 2019 Nov; 55():100941. PubMed ID: 31408714 [TBL] [Abstract][Full Text] [Related]
17. Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice. Roos CM; Zhang B; Palmer AK; Ogrodnik MB; Pirtskhalava T; Thalji NM; Hagler M; Jurk D; Smith LA; Casaclang-Verzosa G; Zhu Y; Schafer MJ; Tchkonia T; Kirkland JL; Miller JD Aging Cell; 2016 Oct; 15(5):973-7. PubMed ID: 26864908 [TBL] [Abstract][Full Text] [Related]
18. Senolytic targets and new strategies for clearing senescent cells. Ge M; Hu L; Ao H; Zi M; Kong Q; He Y Mech Ageing Dev; 2021 Apr; 195():111468. PubMed ID: 33741395 [TBL] [Abstract][Full Text] [Related]